Ithaka’s highly experienced team of scientific experts and entrepreneurs can provide management support across all sectors of the life science industry. The principal services that we offer are focussed on the development of early stage opportunities from concept through to exit and are described in outline below:

Due diligence, technical/commercial/intellectual property review of business opportunities (including business plan appraisal)
Ithaka has a proven methodology for undertaking due diligence and technical/commercial/IP reviews to assess the potential of emerging technologies.

Market assessments and evaluation
We have proven expertise in market assessment and have undertaken a significant number of reviews including market research facilitated through direct interviews with potential UK and International customers and development partners.

Development of business strategy and identifying early licensing opportunities
Ithaka has a track record of success in working alongside clients to develop effective business plans for presentation to potential funders Our role often includes the implementation of business strategies to realise maximum value from the opportunity including licensing deals and other commercial routes such as R&D collaborations and strategic alliances.

Company formation
Ithaka has assisted a growing number of clients to form companies. We can draw on additional expert support from a network of professional advisors to facilitate the set up process.

Management services
We are experienced in complementing the management team by acting in a Chairman, CEO, business development or project management role on an interim basis to execute the commercial strategy.

Sourcing finance
Our success to date in raising more than £15 million of funds for clients demonstrates our ability to open doors to providers of early stage finance. We have a wide network of personal contacts in the Life Science investor community throughout Europe.

Business development and corporate partnering
The Ithaka team has assisted many clients to negotiate commercial transactions. We can provide access to a wide network of international business contacts (including major pharmaceutical companies).

Exit strategies
We are experienced in identifying, assessing and helping to realise exit strategies including merger and acquisition (UK and transatlantic), and management buy-in or management buy-out.